Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators.

Martinet L, Naômé A, Deflandre B, Maciejewska M, Tellatin D, Tenconi E, Smargiasso N, de Pauw E, van Wezel GP, Rigali S.

MBio. 2019 Aug 13;10(4). pii: e01230-19. doi: 10.1128/mBio.01230-19.

2.

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model.

Guillerey C, Nakamura K, Pichler AC, Barkauskas D, Krumeich S, Stannard K, Miles K, Harjunpää H, Yu Y, Casey M, Doban AI, Lazar M, Hartel G, Smith D, Vuckovic S, Teng MW, Bergsagel PL, Chesi M, Hill GR, Martinet L, Smyth MJ.

JCI Insight. 2019 Jun 13;5. pii: 125932. doi: 10.1172/jci.insight.125932.

3.

Human peripheral blood DNAM-1neg NK cells are a terminally differentiated subset with limited effector functions.

Stannard KA, Lemoine S, Waterhouse NJ, Vari F, Chatenoud L, Gandhi MK, Martinet L, Smyth MJ, Guillerey C.

Blood Adv. 2019 Jun 11;3(11):1681-1694. doi: 10.1182/bloodadvances.2018030676.

4.

A procedure to increase the power of Granger-causal analysis through temporal smoothing.

Spencer E, Martinet LE, Eskandar EN, Chu CJ, Kolaczyk ED, Cash SS, Eden UT, Kramer MA.

J Neurosci Methods. 2018 Oct 1;308:48-61. doi: 10.1016/j.jneumeth.2018.07.010. Epub 2018 Jul 19.

PMID:
30031776
5.

TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma.

Guillerey C, Harjunpää H, Carrié N, Kassem S, Teo T, Miles K, Krumeich S, Weulersse M, Cuisinier M, Stannard K, Yu Y, Minnie SA, Hill GR, Dougall WC, Avet-Loiseau H, Teng MWL, Nakamura K, Martinet L, Smyth MJ.

Blood. 2018 Oct 18;132(16):1689-1694. doi: 10.1182/blood-2018-01-825265. Epub 2018 Jul 9.

PMID:
29986909
6.

Ictal and preictal power changes outside of the seizure focus correlate with seizure generalization.

Naftulin JS, Ahmed OJ, Piantoni G, Eichenlaub JB, Martinet LE, Kramer MA, Cash SS.

Epilepsia. 2018 Jul;59(7):1398-1409. doi: 10.1111/epi.14449. Epub 2018 Jun 13.

7.

Complete Genome Sequence of Streptomyces lunaelactis MM109T, Isolated from Cave Moonmilk Deposits.

Naômé A, Maciejewska M, Calusinska M, Martinet L, Anderssen S, Adam D, Tenconi E, Deflandre B, Coppieters W, Karim L, Hanikenne M, Baurain D, Delfosse P, van Wezel GP, Rigali S.

Genome Announc. 2018 May 24;6(21). pii: e00435-18. doi: 10.1128/genomeA.00435-18.

8.

Isolation, Characterization, and Antibacterial Activity of Hard-to-Culture Actinobacteria from Cave Moonmilk Deposits.

Adam D, Maciejewska M, Naômé A, Martinet L, Coppieters W, Karim L, Baurain D, Rigali S.

Antibiotics (Basel). 2018 Mar 22;7(2). pii: E28. doi: 10.3390/antibiotics7020028.

9.

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment.

Nakamura K, Kassem S, Cleynen A, Chrétien ML, Guillerey C, Putz EM, Bald T, Förster I, Vuckovic S, Hill GR, Masters SL, Chesi M, Bergsagel PL, Avet-Loiseau H, Martinet L, Smyth MJ.

Cancer Cell. 2018 Apr 9;33(4):634-648.e5. doi: 10.1016/j.ccell.2018.02.007.

10.

Measuring dynamic social contacts in a rehabilitation hospital: effect of wards, patient and staff characteristics.

Duval A, Obadia T, Martinet L, Boëlle PY, Fleury E, Guillemot D, Opatowski L, Temime L; I-Bird study group.

Sci Rep. 2018 Jan 26;8(1):1686. doi: 10.1038/s41598-018-20008-w.

11.

Contribution of the β-glucosidase BglC to the onset of the pathogenic lifestyle of Streptomyces scabies.

Jourdan S, Francis IM, Deflandre B, Tenconi E, Riley J, Planckaert S, Tocquin P, Martinet L, Devreese B, Loria R, Rigali S.

Mol Plant Pathol. 2018 Jun;19(6):1480-1490. doi: 10.1111/mpp.12631. Epub 2017 Dec 26.

12.

Assessment of the Potential Role of Streptomyces in Cave Moonmilk Formation.

Maciejewska M, Adam D, Naômé A, Martinet L, Tenconi E, Całusińska M, Delfosse P, Hanikenne M, Baurain D, Compère P, Carnol M, Barton HA, Rigali S.

Front Microbiol. 2017 Jun 29;8:1181. doi: 10.3389/fmicb.2017.01181. eCollection 2017.

13.

Human seizures couple across spatial scales through travelling wave dynamics.

Martinet LE, Fiddyment G, Madsen JR, Eskandar EN, Truccolo W, Eden UT, Cash SS, Kramer MA.

Nat Commun. 2017 Apr 4;8:14896. doi: 10.1038/ncomms14896.

14.

A Phenotypic and Genotypic Analysis of the Antimicrobial Potential of Cultivable Streptomyces Isolated from Cave Moonmilk Deposits.

Maciejewska M, Adam D, Martinet L, Naômé A, Całusińska M, Delfosse P, Carnol M, Barton HA, Hayette MP, Smargiasso N, De Pauw E, Hanikenne M, Baurain D, Rigali S.

Front Microbiol. 2016 Sep 21;7:1455. eCollection 2016.

15.

Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.

Blake SJ, Stannard K, Liu J, Allen S, Yong MC, Mittal D, Aguilera AR, Miles JJ, Lutzky VP, de Andrade LF, Martinet L, Colonna M, Takeda K, Kühnel F, Gurlevik E, Bernhardt G, Teng MW, Smyth MJ.

Cancer Discov. 2016 Apr;6(4):446-59. doi: 10.1158/2159-8290.CD-15-0944. Epub 2016 Jan 19.

16.

[Keloid scars (part I): Clinical presentation, epidemiology, histology and pathogenesis].

Philandrianos C, Kerfant N, Jaloux C Jr, Martinet L, Bertrand B, Casanova D.

Ann Chir Plast Esthet. 2016 Apr;61(2):128-35. doi: 10.1016/j.anplas.2015.09.005. Epub 2015 Nov 3. Review. French.

PMID:
26545809
17.

DNAM-1: would the real natural killer cell please stand up!

Huntington ND, Martinet L, Smyth MJ.

Oncotarget. 2015 Oct 6;6(30):28537-8. doi: 10.18632/oncotarget.5952. No abstract available.

18.

Growth of desferrioxamine-deficient Streptomyces mutants through xenosiderophore piracy of airborne fungal contaminations.

Arias AA, Lambert S, Martinet L, Adam D, Tenconi E, Hayette MP, Ongena M, Rigali S.

FEMS Microbiol Ecol. 2015 Jul;91(7). pii: fiv080. doi: 10.1093/femsec/fiv080. Epub 2015 Jul 15.

19.

Natural Killer cell control of BRAFV600E mutant melanoma during targeted therapy.

de Andrade LF, Ngiow SF, Martinet L, Smyth MJ.

Oncoimmunology. 2015 Apr 1;4(4):e998119. eCollection 2015 Apr.

20.

Slow Spatial Recruitment of Neocortex during Secondarily Generalized Seizures and Its Relation to Surgical Outcome.

Martinet LE, Ahmed OJ, Lepage KQ, Cash SS, Kramer MA.

J Neurosci. 2015 Jun 24;35(25):9477-90. doi: 10.1523/JNEUROSCI.0049-15.2015.

21.

Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

Guillerey C, Ferrari de Andrade L, Vuckovic S, Miles K, Ngiow SF, Yong MC, Teng MW, Colonna M, Ritchie DS, Chesi M, Bergsagel PL, Hill GR, Smyth MJ, Martinet L.

J Clin Invest. 2015 Jul 1;125(7):2904. doi: 10.1172/JCI82646. Epub 2015 Jun 15. No abstract available.

22.

NK cells require IL-28R for optimal in vivo activity.

Souza-Fonseca-Guimaraes F, Young A, Mittal D, Martinet L, Bruedigam C, Takeda K, Andoniou CE, Degli-Esposti MA, Hill GR, Smyth MJ.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2376-84. doi: 10.1073/pnas.1424241112. Epub 2015 Apr 21.

23.

Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

Guillerey C, Ferrari de Andrade L, Vuckovic S, Miles K, Ngiow SF, Yong MC, Teng MW, Colonna M, Ritchie DS, Chesi M, Bergsagel PL, Hill GR, Smyth MJ, Martinet L.

J Clin Invest. 2015 May;125(5):2077-89. doi: 10.1172/JCI77181. Epub 2015 Apr 20. Erratum in: J Clin Invest. 2015 Jul 1;125(7):2904. Chesi, Martha [corrected to Chesi, Marta].

24.

DNAM-1 expression marks an alternative program of NK cell maturation.

Martinet L, Ferrari De Andrade L, Guillerey C, Lee JS, Liu J, Souza-Fonseca-Guimaraes F, Hutchinson DS, Kolesnik TB, Nicholson SE, Huntington ND, Smyth MJ.

Cell Rep. 2015 Apr 7;11(1):85-97. doi: 10.1016/j.celrep.2015.03.006. Epub 2015 Mar 26.

25.

Balancing natural killer cell activation through paired receptors.

Martinet L, Smyth MJ.

Nat Rev Immunol. 2015 Apr;15(4):243-54. doi: 10.1038/nri3799. Epub 2015 Mar 6. Review.

PMID:
25743219
26.

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma.

Ferrari de Andrade L, Ngiow SF, Stannard K, Rusakiewicz S, Kalimutho M, Khanna KK, Tey SK, Takeda K, Zitvogel L, Martinet L, Smyth MJ.

Cancer Res. 2014 Dec 15;74(24):7298-308. doi: 10.1158/0008-5472.CAN-14-1339. Epub 2014 Oct 28.

27.

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.

Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, Town L, Ritchie DS, Colonna M, Andrews DM, Smyth MJ.

Nat Immunol. 2014 May;15(5):431-8. doi: 10.1038/ni.2850. Epub 2014 Mar 23.

PMID:
24658051
29.

DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.

de Andrade LF, Smyth MJ, Martinet L.

Immunol Cell Biol. 2014 Mar;92(3):237-44. doi: 10.1038/icb.2013.95. Epub 2013 Dec 17. Review.

PMID:
24343663
30.

High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.

Martinet L, Filleron T, Le Guellec S, Rochaix P, Garrido I, Girard JP.

J Immunol. 2013 Aug 15;191(4):2001-8. doi: 10.4049/jimmunol.1300872. Epub 2013 Jul 3.

31.

Molecular mechanisms of natural killer cell activation in response to cellular stress.

Chan CJ, Smyth MJ, Martinet L.

Cell Death Differ. 2014 Jan;21(1):5-14. doi: 10.1038/cdd.2013.26. Epub 2013 Apr 12. Review.

32.

High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.

Martinet L, Le Guellec S, Filleron T, Lamant L, Meyer N, Rochaix P, Garrido I, Girard JP.

Oncoimmunology. 2012 Sep 1;1(6):829-839.

33.
34.

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.

Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP.

Cancer Res. 2011 Sep 1;71(17):5678-87. doi: 10.1158/0008-5472.CAN-11-0431. Epub 2011 Aug 16.

35.

Stimulated γδ T cells increase the in vivo efficacy of trastuzumab in HER-2+ breast cancer.

Capietto AH, Martinet L, Fournié JJ.

J Immunol. 2011 Jul 15;187(2):1031-8. doi: 10.4049/jimmunol.1100681. Epub 2011 Jun 13.

36.

Spatial learning and action planning in a prefrontal cortical network model.

Martinet LE, Sheynikhovich D, Benchenane K, Arleo A.

PLoS Comput Biol. 2011 May;7(5):e1002045. doi: 10.1371/journal.pcbi.1002045. Epub 2011 May 19.

37.

How tumors might withstand γδ T-cell attack.

Capietto AH, Martinet L, Fournié JJ.

Cell Mol Life Sci. 2011 Jul;68(14):2433-42. doi: 10.1007/s00018-011-0705-7. Epub 2011 May 6. Review.

PMID:
21547501
38.

Phosphoantigens overcome human TCRVgamma9+ gammadelta Cell immunosuppression by TGF-beta: relevance for cancer immunotherapy.

Capietto AH, Martinet L, Cendron D, Fruchon S, Pont F, Fournié JJ.

J Immunol. 2010 Jun 15;184(12):6680-7. doi: 10.4049/jimmunol.1000681. Epub 2010 May 17.

39.

PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.

Martinet L, Jean C, Dietrich G, Fournié JJ, Poupot R.

Biochem Pharmacol. 2010 Sep 15;80(6):838-45. doi: 10.1016/j.bcp.2010.05.002. Epub 2010 May 12.

PMID:
20470757
40.

Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses.

Martinet L, Poupot R, Mirshahi P, Rafii A, Fournié JJ, Mirshahi M, Poupot M.

Int J Cancer. 2010 May 1;126(9):2143-52. doi: 10.1002/ijc.24881.

41.

[Perioperative interstitial brachytherapy for recurrent keloid scars].

Rio E, Bardet E, Peuvrel P, Martinet L, Perrot P, Baraer F, Loirat Y, Sartre JY, Malard O, Ferron C, Dreno B.

Cancer Radiother. 2010 Jan;14(1):65-8. doi: 10.1016/j.canrad.2009.05.008. Epub 2009 Aug 19. French.

PMID:
19695929
42.

Pitfalls on the roadmap to gammadelta T cell-based cancer immunotherapies.

Martinet L, Poupot R, Fournié JJ.

Immunol Lett. 2009 May 14;124(1):1-8. doi: 10.1016/j.imlet.2009.03.011. Epub 2009 Mar 31. Review.

PMID:
19465238
43.

A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.

Martinet L, Fleury-Cappellesso S, Gadelorge M, Dietrich G, Bourin P, Fournié JJ, Poupot R.

Eur J Immunol. 2009 Mar;39(3):752-62. doi: 10.1002/eji.200838812.

44.

Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer.

Fruchon S, Poupot M, Martinet L, Turrin CO, Majoral JP, Fournié JJ, Caminade AM, Poupot R.

J Leukoc Biol. 2009 Mar;85(3):553-62. doi: 10.1189/jlb.0608371. Epub 2008 Dec 1.

PMID:
19047518
45.

[Effectiveness of Integra in the management of complete forearm degloving injury. A case report].

Martinet L, Pannier M, Duteille F.

Chir Main. 2007 Apr;26(2):124-6. Epub 2007 Mar 15. French.

PMID:
17470419
46.

Design of phosphorylated dendritic architectures to promote human monocyte activation.

Poupot M, Griffe L, Marchand P, Maraval A, Rolland O, Martinet L, L'Faqihi-Olive FE, Turrin CO, Caminade AM, Fournié JJ, Majoral JP, Poupot R.

FASEB J. 2006 Nov;20(13):2339-51.

PMID:
17077311
49.

Effect of melatonin on the GnRH release by hypothalamic explants of male mink.

Messager S, Caillol M, Martinet L.

Ann N Y Acad Sci. 1998 May 15;839:372-4. No abstract available.

PMID:
9629179

Supplemental Content

Loading ...
Support Center